Cargando…
Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
BACKGROUND AND AIMS: Quetiapine is an atypical antipsychotic predominantly metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme. We studied the risk of adverse events following coprescription of clarithromycin (a strong CYP3A4 inhibitor) versus azithromycin (not a CYP3A4 inhibitor) in quetiapine u...
Autores principales: | Yau, Kevin, McArthur, Eric, Jeyakumar, Nivethika, Tsobo Muanda, Flory, Kim, Richard B., Clemens, Kristin K., Wald, Ron, Garg, Amit X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290079/ https://www.ncbi.nlm.nih.gov/pubmed/37359413 http://dx.doi.org/10.1002/hsr2.1375 |
Ejemplares similares
-
Cardiovascular Safety of Metoclopramide Compared to Domperidone: A Population-Based Cohort Study
por: Cowan, Andrea, et al.
Publicado: (2020) -
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease
por: Muanda, Flory Tsobo, et al.
Publicado: (2022) -
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease
por: Muanda, Flory T., et al.
Publicado: (2023) -
Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study
por: Wang, Yi-Chun, et al.
Publicado: (2016) -
Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)